Search Results - "MacGrogan, Gaetan"

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes.

Authors: Bonnefoi, Hervé MacGrogan, Gaetan Poncet, Coralie et al.

Source: British Journal of Cancer. Apr2019, Vol. 120 Issue 9, p913-921. 9p. 1 Diagram, 3 Charts, 2 Graphs.

A 128-Pixel System-on-a-Chip for Real-Time Super-Resolution Terahertz Near-Field Imaging.

Authors: Hillger, Philipp Jain, Ritesh Grzyb, Janusz et al.

Source: IEEE Journal of Solid-State Circuits; Dec2018, Vol. 53 Issue 12, p3599-3612, 14p

Long-Term Complete Response of an Androgen Receptor-Positive Triple-Negative Metastatic Breast Cancer to Abiraterone Acetate.

Authors: Grellety, Thomas MacGrogan, Gaetan Chakiba, Camille et al.

Source: JCO Precision Oncology. 2018, Vol. 2, p1-0. 6p.

Distinction Between Isolated Tumor Cells and Micrometastases in Breast Cancer.

Authors: de Mascarel, Isabelle MacGrogan, Gaetan Debled, Marc et al.

Source: Cancer (0008543X). 4/15/2008, Vol. 112 Issue 8, p1672-1678. 7p. 2 Diagrams, 5 Charts.

Patterns of genomic change in residual disease after neoadjuvant chemotherapy for estrogen receptor-positive and HER2-negative breast cancer.

Authors: Chatzipli, Aikaterini Bonnefoi, Hervé MacGrogan, Gaetan et al.

Source: British Journal of Cancer. Nov2021, Vol. 125 Issue 10, p1356-1364. 9p.

Multivariate frailty models for two types of recurrent events with a dependent terminal event: Application to breast cancer data.

Authors: Mazroui, Yassin Mathoulin‐Pélissier, Simone MacGrogan, Gaetan et al.

Source: Biometrical Journal. Nov2013, Vol. 55 Issue 6, p866-884. 19p.

Darolutamide or capecitabine in triple-negative, androgen receptor-positive, advanced breast cancer (UCBG 3-06 START): a multicentre, non-comparative, randomised, phase 2 trial.

Authors: Bonnefoi, Hervé Lerebours, Florence Pulido, Marina et al.

Source: Lancet Oncology. Mar2025, Vol. 26 Issue 3, p355-366. 12p.

Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer.

Authors: Quenel-Tueux, Nathalie Debled, Marc Rudewicz, Justine et al.

Source: British Journal of Cancer. 8/11/2015, Vol. 113 Issue 4, p585-594. 10p.

Accumulation of an Endogenous Tryptophan-Derived Metabolite in Colorectal and Breast Cancers.

Authors: Puccetti, Paolo Fallarino, Francesca Italiano, Antoine et al.

Source: PLoS ONE. Apr2015, Vol. 10 Issue 4, p1-9. 9p.

Dynamic prediction of risk of death using history of cancer recurrences in joint frailty models.

Authors: Mauguen, Audrey Rachet, Bernard Mathoulin‐Pélissier, Simone et al.

Source: Statistics in Medicine. Dec2013, Vol. 32 Issue 30, p5366-5380. 15p.

Identification of molecular apocrine breast tumours by microarray analysis.

Authors: Farmer, Pierre Bonnefoi, Herve Becette, Veronique et al.

Source: Oncogene. 7/7/2005, Vol. 24 Issue 29, p4660-4671. 12p.

Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials.

Authors: Lerebours, Florence Pulido, Marina Fourme, Emmanuelle et al.

Source: British Journal of Cancer. Mar2020, Vol. 122 Issue 6, p759-765. 7p. 1 Diagram, 4 Charts, 1 Graph.

Time-varying coefficients in a multivariate frailty model: Application to breast cancer recurrences of several types and death.

Authors: Mazroui, Yassin Mauguen, Audrey Mathoulin-Pélissier, Simone et al.

Source: Lifetime Data Analysis. Apr2016, Vol. 22 Issue 2, p191-215. 25p.

High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: A multicentre GEFPICS study

Authors: Lacroix-Triki, Magali Mathoulin-Pelissier, Simone Ghnassia, Jean-Pierre et al.

Source: European Journal of Cancer. Nov2006, Vol. 42 Issue 17, p2946-2953. 8p.

Shear-wave elastography quantitative assessment of the male breast: added value to distinguish benign and malignant palpable masses.

Authors: Crombé, Amandine Hurtevent-Labrot, Gabrielle Asad-Syed, Maryam et al.

Source: British Journal of Radiology. Feb2018, Vol. 91 Issue 1082, pN.PAG-N.PAG. 1p.

Re: Population-Based Study of Peritumoral Lymphovascular Invasion and Outcome Among Patients With Operable Breast Cancer.

Authors: DEBLED, MARC DE MASCAREL, ISABELLE BROUSTE, VERONIQUE et al.

Source: JNCI: Journal of the National Cancer Institute. 2/24/2010, Vol. 102 Issue 4, p275-276. 2p. 1 Graph.

Immunosuppressive myeloid cells induce mesenchymal-like breast cancer stem cells by a membrane-bound TGF-β1-dependent mechanism.

Authors: Boyer T Blaye C Chalopin D et al.

Source: Cell reports [Cell Rep] 2026 Jun 18; Vol. 45 (7), pp. 117568. Date of Electronic Publication: 2026 Jun 18.

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial.

Authors: Zerdes I Matikas A Mezheyeuski A et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Mar 07; Vol. 11 (1), pp. 23. Date of Electronic Publication: 2025 Mar 07.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Cancer cells transfer invasive properties through microRNAs contained in collagen tracks.

Authors: Rouyer L Normand L Richard E et al.

Source: Cell reports [Cell Rep] 2025 Dec 23; Vol. 44 (12), pp. 116725. Date of Electronic Publication: 2025 Dec 10.

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Classification of Breast Cancer Through the Perspective of Cell Identity Models.

Authors: Iggo R MacGrogan G

Source: Advances in experimental medicine and biology [Adv Exp Med Biol] 2025; Vol. 1464, pp. 185-207.

Publication Type: Journal Article; Review

Journal Info: Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 0121103 Publication Model: Print Cited Medium: Print ISSN: 0065-2598 (Print) Linking ISSN: 00652598 NLM ISO Abbreviation: Adv Exp Med Biol Subsets: MEDLINE